Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memory reconsolidation as a treatment for nicotine addiction (propranolol)
2018-002829-33Phase 4Active
- Sponsor
- TNO
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of propranolol in nicotine dependence, sponsored by TNO. Started Oct 2018; status: active.
02
Drugs
propranolol
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2018-002829-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002829-33.